Hologic may close Wisconsin Dx plant following $3.7B Gen-Probe merger
Hologic may shutter Wisconsin diagnostics manufacturing facility within 18 months of closing its $3.7 billion merger with Gen-Probe, according to an internal memo.
Massachusetts-based women's health devices maker Hologic (NSDQ:HOLX) may shutter a Madison, Wisc. manufacturing facility, according to an internal memo obtained by the Milwaukee-Wisconsin Journal Sentinel.
The closure will "likely" take place within 18 months of closure of Hologic's $3.7 billion Gen-Probe acquisition, according to a memo dated June 13.
The Madison plant houses molecular diagnostics maker Third Wave Technologies, which Hologic acquired for $580 million in 2008 and which has been a bit of a drag ever since.